Expanded labeling for sacubitril/valsartan (Entresto, Novartis) to include adults with chronic heart failure (HF) with left ventricular ejection fraction (LVEF)
Continue reading »
Home »
New ESC guidelines for diagnosis and treatment of heart failure published
The European Society of Cardiology (ESC) Guidelines for the diagnosis and treatment of acute and chronic heart failure are published
Continue reading »
Study: Any form of exercise may not be the most effective prognostic tool for heart failure patients
While exercise therapy for heart failure (HF) patients with low heart function has been shown to be an effective prognostic
Continue reading »
IV Iron Can Save Costs in HF With Iron Deficiency in Analysis
Intravenous iron therapy was predicted to be highly cost-effective or even cost-saving when used in high-risk, iron-deficient patients with heart
Continue reading »
Pneumonia Risk Soars in Heart Failure Patients, Especially HFpEF
Patients with heart failure get pneumonia at a rate almost three times greater than expected and, once they do get
Continue reading »
Heart failure and stroke are on the rise in men below the age of 40, finds study
Heart failure and stroke are unusual diagnoses among younger people. But they are now clearly on the rise in men
Continue reading »
Ramace
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. RAMACE® Ramipril Consumer Medicine Information What is
Continue reading »
Plendil ER
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. PLENDIL® ER Felodipine Consumer Medicine Information What
Continue reading »
APO-Metformin XR
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-METFORMIN XR Contains the active ingredient metformin
Continue reading »
Terry White Chemists Bisoprolol
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TERRY WHITE CHEMISTS BISOPROLOL Bisoprolol fumarate Consumer
Continue reading »